Mutual Fund Details
NAV
₹10.6600
as on 13 Dec 2019, 10:45 PM
₹0.0300(0.28%)
Last Change
Schemes Managed By
Start SIP in this Mutual Fund
Min SIP Amount
₹500
Suggested Date
1st of Every Month
Investment Performance
would have given a return of
₹100,875
₹101,687
₹101,733
₹102,211
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
₹2,212
Profit (absolute return)
2.21%
in the last
1m
3m
max
+1% Higher Returns
With Direct Plans on Paytm MoneyInvestment Returns
In the last 3 months
2.21%
In the last 6 months
NA
In the last 1 year
NA
In the last 3 years
NA
In the last 5 years
NA
In the last 10 years
NA
Absolute Returns
CAGR
Scheme Riskometer
low
moderately low
moderate
moderately high
high
Investors understand that their principal will be at high risk
Scheme Information
Aditya Birla Sun Life Pharma & Healthcare Fund Direct - Dividend
as of 13 Dec 2019, 10:45 PM
₹170.53 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 0.5% if redeemed within 90 days.
0.91%
Expense Ratio
Plan
Dividend
Benchmark
S&P BSE Healthcare Total Return Index
Exit Load
Exit load of 0.5% if redeemed within 90 days.
Scheme Document
Sectors Holding in this Mutual Fund
as on 31 Oct 2019
Healthcare
83.86%
₹143.01 Cr
Chemicals
5.36%
₹9.15 Cr
FMCG
3.27%
₹5.57 Cr
Financial
2.20%
₹3.76 Cr
Cash Holding
-15.50%
₹-26.44 Cr
Companies Holding in this Mutual Fund
as on 31 Oct 2019
Sun Pharmaceutical Inds. Ltd.
11.05%
₹18.84 Cr
Cipla Ltd.
9.18%
₹15.65 Cr
Lupin Ltd.
7.92%
₹13.51 Cr
Alkem Laboratories Ltd.
5.80%
₹9.89 Cr
Divi's Laboratories Ltd.
5.41%
₹9.23 Cr
Atul Ltd.
5.36%
₹9.14 Cr
Others
5.30%
₹9.04 Cr
Apollo Hospitals Enterprise Ltd.
4.79%
₹8.17 Cr
Torrent Pharmaceuticals Ltd.
4.69%
₹8.00 Cr
Dr. Reddy's Laboratories Ltd.
4.52%
₹7.71 Cr
View All
View All
Companies Holding in this Mutual Fund
as on 31 Oct 2019
Sun Pharmaceutical Inds. Ltd.
11.05%
₹18.84 Cr
Cipla Ltd.
9.18%
₹15.65 Cr
Lupin Ltd.
7.92%
₹13.51 Cr
Alkem Laboratories Ltd.
5.80%
₹9.89 Cr
Divi's Laboratories Ltd.
5.41%
₹9.23 Cr
Atul Ltd.
5.36%
₹9.14 Cr
Others
5.30%
₹9.04 Cr
Apollo Hospitals Enterprise Ltd.
4.79%
₹8.17 Cr
Torrent Pharmaceuticals Ltd.
4.69%
₹8.00 Cr
Dr. Reddy's Laboratories Ltd.
4.52%
₹7.71 Cr
View All
View All
This fund's returns:
2.21%Return Duration
3 Months
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
EquityPharma
Min. Investment
₹100
Category Returns
2.30%
6.17%
3M Returns
6.17
Nippon India Pharma Fund Direct-Growth
EquityPharma
Min. Investment
₹100
Category Returns
2.30%
6.17%
3M Returns
5.60
IDBI Healthcare Fund Direct - Growth
EquityPharma
Min. Investment
₹500
Category Returns
2.30%
6.17%
3M Returns
5.54
UTI Healthcare Fund Direct-Growth
EquityPharma
Min. Investment
₹500
Category Returns
2.30%
6.17%
3M Returns
5.45
SBI Healthcare Opportunities Fund Direct Plan-Growth
EquityPharma
Min. Investment
₹500
Category Returns
2.30%
6.17%
3M Returns
4.97
About Aditya Birla Sun Life Pharma & Healthcare Fund Direct - Dividend
Aditya Birla Sun Life Pharma & Healthcare Fund Direct - Dividend is a Equity mutual fund scheme from Aditya Birla Sun Life Mutual Fund. This scheme was launched on 10 Jul 2019 and is currently managed by its fund manager Dhaval Shah. It has an AUM of ₹170.53 Crores and the latest NAV decalared is ₹10.660 as on 13 Dec 2019 at 10:45 pm.
Aditya Birla Sun Life Pharma & Healthcare Fund Direct - Dividend scheme return performance is 6.07% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.
Scheme Details
| AUM: | ₹170.53 Cr |
| Category: | Equity: Sectoral-Pharma |
| Launch Date: | 10 Jul 2019 |
| Fund Type: | Open-End |
Scheme Objective
The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
AMC Information
Aditya Birla Sun Life Mutual Fund
View AMC Details
₹247,738.14 Cr
AUM
110
Schemes
Address
One India Bulls Center - Tower 1,17th Floor - Jupiter Mills Compound,841 Senapati Bhawan, Elphinstone Road,400013
Phone Number
Phone : 022-43568000 / 1800-270-7000 / 1800-22-7000
Fax : 022-43568110
Email / Website
